April 13, 2023

Artarmon, NSW & Bloomington, MN – April 13, 2023 – Saluda Medical Inc. (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders, today announced the closing of a US $150 million equity financing round led by new investor Wellington Management, with strong support from current investor Fidelity Management & Research Company and new investor TPG. Current investors Redmile Group, LLC, Action Potential Venture Capital and funds and accounts advised by T. Rowe Price Associates, Inc. also participated. Laureen DeBuono, Managing Partner at FLG is a Director and Chair of the Audit and Finance Committee.

Full press release is here.